Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 10 603,5 kr, with a 24-hour trading volume of 34,74B kr. The asset's market cap is 9,49T kr, after moving -0.05% in the last day.
Tokenized Eli Lilly And Co is trading at 10 635,72 kr, with a tokenized market cap of 56,72M kr and a 24-hour trading volume of 20,78M kr. The tokenized asset has moved -1.06% in the past 24 hours.